New developments in type 2 diabetes care Montreal diabetes prevention clinic said to be first of its kind in Canada Study examines risk of serious adverse events with SGLT2 inhibitors in type 2 diabetes Finds twofold increases in the risk of lower limb amputation and diabetic ketoacidosis 2018 Consolidated Canadian guideline for preventing and managing cardiovascular disease in primary care C-CHANGE guideline combines recommendations from nine Canadian cardiovascular-related guidelines to meet primary care needs Pharmacist pushes for free access to insulin pen needles in Ontario In a quest to get insulin pen needles covered under Ontario’s provincial drug plan, one pharmacist is taking matters into her own hands. Combination therapy safe and effective in older type 2 diabetes patients New study examines 'real-world' safety and efficacy of GLP-1 agonist and SGLT-2 inhibitor combo when used in elderly patients with suboptimal glycemic control Second basal insulin/GLP-1 agonist combo for type 2 diabetes now available Glargine–lixisenatide combo joins degludec–liraglutide combo on Canadian market Foot self-care for patients with diabetes What's new in the latest diabetes clinical practice guidelines? Travel tips for patients with diabetes Help prepare your patients for safe travel near home or abroad First Previous 21 22 23 24 25 Next Last
